StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
APIS.BO$63.58+0.68%
Fair $63.58+0.0%

APIS.BO

APIS.BO

Consumer Defensive / Packaged FoodsBSE

$63.58

+0.43 (+0.68%)

Fairly Valued+0.0%Fair Value $63.58Fund rank 27/100 · Data gapFallback financials|
SA 46/C
F-Score: 4/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 20%

FCF escenarios

weak_data · normalized FCF $15.3M · quality 45.0/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 23/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

46/100

C

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · APIS.BOLocal privado en este navegador · APIS.BO
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$8.8B

P/E

34.6x

↑

EV/EBITDA

25.2x

↑

ROE

14.6%

↑

Gross Margin

31.6%

↑

Debt/Equity

0.38

↑
52-Week Range$64
$12$110

TradingView lightweight chart

APIS.BO price, volumen y niveles de valoración

Último $63.58Periodo +27.2%
Fair value: $63.58

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+6.0%

FCF CAGR

-44.5%

FCF margin

0.4%

FCF / Net income

0.06x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $3.46B · net income $253.4M · FCF $15.3M

2022-FY → 2025-FY

Gross margin

31.6%+2.2% pts

Operating margin

8.4%+4.0% pts

Net margin

7.3%+4.6% pts

FCF margin

0.4%-2.6% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$3.46B$3.46B$3.14B$3.27B$2.91B
Net Income$253.4M$253.4M$325.7M$182.5M$79.8M
EBITDA$374.2M$374.2M$347.3M$228.6M$190.1M
EPS1.841.842.361.330.54
Gross Margin31.6%31.6%34.6%25.8%29.4%
Operating Margin8.4%8.4%10.1%5.4%4.4%
Net Margin7.3%7.3%10.4%5.6%2.7%
Balance Sheet
Debt/Equity0.380.380.410.651.07
Cash Flow
Free Cash Flow$15.3M$15.3M$-69.7M$157.1M$89.7M
Returns
ROE14.6%14.6%22.0%15.8%8.2%
Valuation
P/E34.5734.573.211.851.34
EV/EBITDA25.1725.174.744.715.85
P/B5.065.060.710.290.10
Growth & Yield
Revenue Growth10.2%10.2%-4.0%12.5%—
EPS Growth-22.2%-22.2%78.4%146.5%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

45.3%

muy exigente

EPS terminal req.

$5.64

Spread vs growth

-67.5%

5Y implied EPS CAGR

30.0%

muy exigente

EPS terminal req.

$6.83

Spread vs growth

-52.2%

10Y implied EPS CAGR

19.6%

exigente

EPS terminal req.

$10.99

Spread vs growth

-41.8%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +439.9%

Total return

+439.9%

Start / end P/E

5.0x → 34.6x

EPS bridge

2.36 → 1.84

Residual

-131.9%

EPS growth-22.2%
Multiple rerating+594.0%
Dividend+0.0%
Residual / FX / buybacks / cross-term-131.9%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.